Published in:
Open Access
01-12-2015 | Research
In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAF
V600E in melanoma
Authors:
Xingyi Guo, Yaomin Xu, Zhongming Zhao
Published in:
Molecular Cancer
|
Issue 1/2015
Login to get access
Abstract
Background
The recurrent BRAF driver mutation V600E (BRAF
V600E) is currently one of the most clinically relevant mutations in melanoma. However, the genome-wide transcriptional and epigenetic dysregulations induced by BRAF
V600E are still unclear. The investigation of this driver mutation’s functional consequences is critical to the understanding of tumorigenesis and the development of therapeutic strategies.
Methods and results
We performed an integrative analysis of transcriptomic and epigenomic changes disturbed by BRAF
V600E by comparing the gene expression and methylation profiles of 34 primary cutaneous melanoma tumors harboring BRAF
V600E with those of 27 BRAF
WT samples available from The Cancer Genome Atlas (TCGA). A total of 711 significantly differentially expressed genes were identified as putative BRAF
V600E target genes. Functional enrichment analyses revealed the transcription factor MITF (p < 3.6 × 10−16) and growth factor TGFB1 (p < 3.1 × 10−9) were the most significantly enriched up-regulators, with MITF being significantly up-regulated, whereas TGFB1 was significantly down-regulated in BRAF
V600E, suggesting that they may mediate tumorigenesis driven by BRAF
V600E. Further investigation using the MITF ChIP-Seq data confirmed that BRAF
V600E led to an overall increased level of gene expression for the MITF targets. Furthermore, DNA methylation analysis revealed a global DNA methylation loss in BRAF
V600E relative to BRAF
WT. This might be due to BRAF dysregulation of DNMT3A, which was identified as a potential target with significant down-regulation in BRAF
V600E. Finally, we demonstrated that BRAF
V600E targets may play essential functional roles in cell growth and proliferation, measured by their effects on melanoma tumor growth using a short hairpin RNA silencing experimental dataset.
Conclusions
Our integrative analysis identified a set of BRAF
V600E target genes. Further analyses suggested a complex mechanism driven by mutation BRAF
V600E on melanoma tumorigenesis that disturbs specific cancer-related genes, pathways, and methylation modifications.